Scott Kollins - Akili Chief Officer

AKLIDelisted Stock  USD 0.43  0.00  0.00%   

Insider

Scott Kollins is Chief Officer of Akili Inc
Phone617 313 8853
Webhttps://www.akiliinteractive.com

Akili Management Efficiency

The company has return on total asset (ROA) of (0.3662) % which means that it has lost $0.3662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6806) %, meaning that it created substantial loss on money invested by shareholders. Akili's management efficiency ratios could be used to measure how well Akili manages its routine affairs as well as how well it operates its assets and liabilities.
Akili Inc currently holds 15.48 M in liabilities with Debt to Equity (D/E) ratio of 0.79, which is about average as compared to similar companies. Akili Inc has a current ratio of 4.68, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Akili's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Daniel BartonForian Inc
59
Jason AlgerHealth Catalyst
40
Max WygodForian Inc
36
Jason JonesHealth Catalyst
N/A
Jim GrauelFOXO Technologies
N/A
Daniel BurtonHealth Catalyst
49
Jacob GoldbergerStreamline Health Solutions
N/A
Amy SeberoStreamline Health Solutions
N/A
John LorbieckiAclarion
61
Wendy LucioStreamline Health Solutions
N/A
Michael VeseyForian Inc
62
Jona RaaschNational Research Corp
65
Tyson MurdockHealthEquity
53
Dave RossHealth Catalyst
N/A
Brian ChenFOXO Technologies
N/A
Jon BoumsteinNational Research Corp
N/A
Paul HorstmeierHealth Catalyst
63
Steven SobakEUDA Health Holdings
78
Susan NeoFOXO Technologies
N/A
David TerrellForian Inc
N/A
CPA CPANational Research Corp
66
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. Akili operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 127 people. Akili Inc (AKLI) is traded on NASDAQ Exchange in USA and employs 68 people.

Management Performance

Akili Inc Leadership Team

Elected by the shareholders, the Akili's board of directors comprises two types of representatives: Akili inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akili. The board's role is to monitor Akili's management team and ensure that shareholders' interests are well served. Akili's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akili's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Gottlieb, Chief Officer
Scott Kollins, Chief Officer
Jacqueline JD, General Officer
Barrie Brian, VP People
Adam MD, Chief Cofounder
Walter II, CoFounder Chairman
Julie DiCarlo, VP Communications
Jonathan David, Chief Officer
Santosh Shanbhag, CFO Treasurer
Matthew MBA, CEO President
Matthew Omernick, CoFounder Officer
Caty Reid, VP Communications
Walter Martucci, CEO CoFounder

Akili Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Akili a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Akili Stock

If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk